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Abstract
           
               Electrophysiologic testing and radiofrequency ablation have evolved as curative 
measures for a variety of rhythm disturbances.  As experience in this field has grown, ablation is 
progressively being used to address more complex rhythm disturbances. Paralleling this trend are 
technological advancements to facilitate these efforts, including  electroanatomic mapping 
(EAM).  At present, several different EAM systems utilizing various technologies are available 
to facilitate  mapping and ablation.  Use of these systems has been shown to reduce fluoroscopic 
exposure and radiation dose, with less significant effects on procedural duration and success 
rates.   Among the data provided by EAM are chamber reconstruction, tagging of important 
anatomic landmarks and ablation lesions, display of diagnostic and mapping catheters without 
using fluoroscopy, activation mapping, and voltage (or scar) mapping.  Several EAM systems 
have specialized features, such as enhanced ability to map non-sustained or hemodynamically 
unstable arrhythmias, ability to display diagnostic as well as mapping catheter positions, and 
wide compatibility with a variety of catheters.   Each EAM system has its strengths and 
weaknesses, and the system chosen must depend upon what data is required for procedural 
success (activation mapping, substrate mapping, cardiac geometry), the anticipated arrhythmia, 
the compatibility of the system with adjunctive tools (i.e. diagnostic and ablation catheters), and 
the operator's familiarity with the selected system.  While EAM can offer significant assistance 
during an EP procedure, their incorrect or inappropriate application can substantially hamper 
mapping efforts and procedural success, and should not replace careful interpretation of data and 
strict adherence to electrophysiologic principles.                                            
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               Electrophysiologic (EP) testing and radiofrequency ablation (RFA) have evolved as 
curative measures for a variety of rhythm disturbances.1-3   While originally applied towards 
relatively straightforward arrhythmias with a single discrete target site (such as atrioventricular 
[AV] nodal reentry or tachycardias associated with Wolff-Parkinson-White syndrome), they are 
increasingly being used to address more complex arrhythmias, including atypical atrial flutter, 
atrial fibrillation, and ventricular tachycardia.  This latter group of rhythm disturbances is often 
associated with significant underlying structural cardiac abnormalities, such as congenital, 
ischemic and post-surgical heart disease. Fortunately, the broader use of EP testing and RFA in 
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such   individuals   has   been   accompanied   by   technological   enhancements   to   address   this 
progression. Electroanatomic mapping (EAM) is one such advancement, allowing operators to 
record intracardiac electrical activation in relation to anatomic location in a cardiac chamber of 
interest,  during  arrhythmia  mapping.   Several  EAM  systems  are currently  available  that 
accomplish these tasks. When applied properly, such technology allows one to accurately 
determine   the   location   of   arrhythmia   origin,   define   cardiac   chamber   geometry   in   three 
dimensions,   delineate   areas   of   anatomic   interest,   and   allow   catheter   manipulation   and 
positioning without fluoroscopic guidance. These systems often simplify mapping efforts and 
can enhance procedural success, particularly in cases in which complex arrhythmias and unusual 
cardiac anatomy are encountered.                                                                                         
Why use an EAM system?                                                                                   
            While having an EAM system available for every procedure may seem like an advantage, 
their expense and the additional preparatory time must be justified.  This may be relatively easy 
to   do   when   complex   arrhythmias   or   cardiac   anatomy   are   anticipated.   When   available 
information suggests an arrhythmia mechanism located near important structures such as a 
manifest bypass tract originating near the AV node, EAM may allow for marking of such 
structures so that they may be avoided.  Similarly, when complex anatomy and areas of scar 
contributing to macroreentry are anticipated, EAM may allow demarcation of such regions so 
that they may be isolated.  Non-sustained tachycardias or rapid rhythm disturbances resulting in 
hemodynamic compromise lend themselves well to certain EAM systems, as suspected sites of 
tachycardia origin may be more accurately recorded and targeted for ablation than with 
fluoroscopy alone.  Chief among these, however, is EAM's ability to reliably allow catheter 
positioning without the use of fluoroscopy, a distinct advantage for both patient and operator.
               Several studies have confirmed these advantages, with comparable success rates to 
conventional, non-EAM guided approaches. Fluoroscopy time and radiation dose are indeed 
reduced with EAM when compared to conventional mapping strategies.  This is true for a variety 
of rhythm disturbances including AV node reentry and bypass tract-mediated arrhythmias.4-7         
Variable results have been shown when EAM systems are applied to atrial flutter though overall 
reductions in these parameters have also been demonstrated.4,5,7-11 Shortened procedure duration 
is also apparent in several of these series, though many have shown only a neutral effect of EAM 
on procedural time.                                                                                                
               Perhaps the greatest impact of EAM is its application to facilitate pulmonary vein 
isolation for treatment for atrial fibrillation - EAM use is consistently associated with reduced 
fluoroscopy time, radiation dose, and procedure time.12-14 However, these relative benefits of 
EAM systems must be weighed against their added expense, which was increased by 50% in one 
series.7
Biosense   CARTO®   mapping   system                                                              
            As the CARTO mapping system is arguably the most widely used mapping system, it 
will be the focus of the following discussion.                                                                   
            The CARTO mapping system (Biosense, Diamond Bar, CA, USA) utilizes a low-level 
magnetic field (5 x 10-6 to 5 x 10-5 Tesla) delivered from three separate coils in a locator pad 
beneath the patient. (Figure 1)  The magnetic field strength from each coil is detected by a 
location sensor embedded proximal to the tip of a specialized mapping catheter.  The strength of 
each coil's magnetic field measured by the location sensor is inversely proportional to the 
distance between the sensor and coil.   Hence, by integrating each coil's field strength and 
converting this measurement into a distance, the location sensor (and therefore, catheter tip 
location) can be triangulated in space.15 The mapping catheter has proximal and distal electrode 
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pairs, and a tip electrode capable of radiofrequency energy delivery. This catheter can be moved 
along a chamber's surface to record local endocardial activation times for arrhythmia mapping, 
while simultaneously recording location points to generate 3D chamber geometry.  Validation 
studies have shown CARTO to have substantial accuracy in navigating to single points, in 
returning   to   prior   ablation   sites,   and  in   creating   a  desired   length   of   ablation   line.15-17  
Electrograms recorded from the specialized mapping (NaviSTAR) catheter showed excellent 
correlation with recordings from standard EP catheters.15  Human validation studies have shown 
a similar level of spatial precision and accuracy, and realistic reconstruction of chamber 
geometry and electroanatomic activation during arrhythmia mapping.18  Advantages of CARTO 
include accurate representation of chamber geometry and the capability of generating isochronal 
activation maps and playable propagation maps.  It also has the capability to record locations of 
important anatomic landmarks (such as the bundle of His), areas of electrical scar (to create 
voltage/scar maps) and vessels (coronary sinus [CS], pulmonary veins [PVs]).  CARTO also 
allows recording ablation lesion location facilitating creation of ablation lines.  Disadvantages 
include requiring the use of a specialized (NaviSTAR) catheter, inability to easily relocate a 
displaced reference catheter, somewhat orthogonal appearance to chamber geometry (as when a 
small number of location points are stored), and the inability to record or display the location of 
diagnostic/reference catheters. 
Figure 1: Illustration demonstrating operation of the Biosense CARTO electroanatomic mapping system.  Three 
separate coils emit a low-level magnetic field, diagrammatically represented by color-coded hemispheres.  The field 
strength from each coil is measured by a sensor within the tip of a specialized mapping/ablation catheter, and its 
position   relative   to   each   coil   is   then   triangulated.                                                      
Set-up of the CARTO mapping system                                                                       
Location   reference                                                                      
            Prior to arrhythmia mapping, a stable location reference must be established. This is 
accomplished by placing the location magnet, a triangular apparatus containing three magnetic 
coils, beneath the patient and table. The location of this magnet must be aligned anywhere inside 
a defined circumference at the start of the procedure.  A reference patch is affixed to the patient's 
back roughly overlying the cardiac chamber of interest. Should the location reference magnet or 
patch become displaced during the procedure, their original location is recorded by CARTO to 
allow proper repositioning. This allows for accurate tracking of mapping catheter position, 
consistency of anatomic landmark and ablation lesion locations, and precise reconstruction of 
chamber   geometry.                                                                              
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Activation   mapping   with   CARTO                                                              
             Once the location reference has been stably situated, an appropriate timing reference and 
window must be selected. (Figure 2)  The timing reference is any arbitrarily selected recording 
(intracardiac electrogram [EGM] or surface ECG lead) representative of activation of the 
chamber   of  arrhythmia  origin  (i.e.   proximal   CS  atrial  EGM  chosen  for  mapping   atrial 
tachycardia [AT]). Intracardiac EGMs are often selected as the timing reference as these are 
generally more consistent in appearance and precise in timing than surface ECG recordings, and 
consequently, are more reliable.  For rhythm disturbances where atrial activation is to be mapped 
(premature atrial complexes, AT, concealed bypass tract), the CS is a suitable choice as a timing 
reference, due to its stable positioning and lower likelihood of being dislodged and disrupting 
activation mapping (compared to a high right atrial catheter, for example, that may be dislodged 
by a roving mapping catheter). Any component of the reference electrogram may be chosen for a 
timing reference, including maximum (peak positive) deflection, minimum (peak negative) 
deflection,   maximum   upslope   (dV/dT)   or   maximum   downslope.   The   proximal/mid   CS 
electrodes are often selected as a timing reference as the atrial EGM in these poles are often of 
greater amplitude and fidelity than their ventricular counterparts, preventing inappropriate timing 
using the ventricular EGM.  Such inaccurate results can be observed if the distal CS electrodes 
are selected as the timing reference, for example, where the ventricular EGM amplitude is 
equivalent to, or even larger than the atrial EGM. The ventricular  EGM may then be 
inappropriately taken as the timing reference yielding an incorrect and confusing activation map. 
When mapping ventricular tachycardias or premature ventricular complexes, a right ventricular 
apical recording may be chosen as a stable timing reference for ventricular activation.
            The timing window refers to the range of activation times surrounding reference EGM 
activation.  Proper timing window definition requires accurate determination of the underlying 
tachycardia   mechanism   (focal   versus   macroreentrant   tachycardia);   erroneously   diagnosed 
tachycardia   mechanism   will   result   in   vastly   incorrect   timing   window   definition   and 
consequently, creation of an invalid activation map. Once the correct tachycardia mechanism has 
been diagnosed, the timing window may be defined to include the extremes of cardiac activation 
preceding and following reference EGM activation. (Figure 2) Propagation maps can also be 
constructed and played back from data obtained through activation mapping, demonstrating 
spread of activation throughout a cardiac chamber during arrhythmia.   Figures 3 - 6  are 
examples of activation maps from focal and macroreentrant mechanisms, and figures 7 and 8 
show propagation maps of focal and reentrant arrhythmias, respectively.
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Figure 2: Annotation window for the CARTO mapping system.  Represented from top to bottom are ECG leads I, 
II, III, and V1, followed by distal mapping catheter electrogram (M1-M2) and reference electrogram (R1-R2).  In 
this example, atrial flutter (cycle length 268 ms) is being mapped and a mid-CS recording site has been selected as 
the reference channel.  The clear area surrounded by fine yellow lines is the timing window of interest; the left and 
right boundaries representing operator-defined earliest (-130 ms) and latest (+135 ms) endocardial activation, 
relative to the reference electrogram.  The magenta dot in the mapping catheter electrogram indicates the timing 
onset of local activation while the green dot (arrow) indicates the timing onset of the reference electrogram.
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Figure 3:  Left panel - Right atrial activation map during focal left AT, left anterior oblique (LAO) view.  
Represented anatomic structures include the superior and inferior vena cava (SVC and IVC, respectively), tricuspid 
orifice, bundle of His (orange points), and CS. Yellow points represent anatomic landmarks from which the 
tricuspid orifice is reconstructed.  As expected, earliest RA activation occurs over a broad area in the interatrial 
septum, marked by the red isochrone (arrow) with emanation throughout the RA according to the color-coded time 
scale.  The right panel shows an activation map of both atria (LAO view) once the LA was accessed, mapped, and 
the activation data added to the map.  The site of earliest activation is in the medial LA, and the color coded 
isochrones are adjusted accordingly.  The anatomic locations of the PVs were recorded during LA mapping and 
displayed.   LS = left superior, LI = left inferior, RS = right superior, RI = right inferior.
Figure 4:  Activation map of focal LV tachycardia, right anterior oblique (RAO) and LAO views.   The red 
isochrone indicates earliest ventricular activation (and therefore, tachycardia origin) emanating from the anterior LV 
free   wall.                                                                                            
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Figure 5: Activation map of the RV outflow tract (RVOT) and aortic sinus in a patient with frequent, symptomatic 
premature ventricular complexes, left lateral view.   The RVOT was initially mapped and demonstrated early 
activation (orange isochrone) in its anteroseptal aspect.  Mapping of the aortic sinus, however, revealed even earlier 
activation as evidenced by the red isochrone, with uniform, centrifugal spread, to the adjacent RVOT.  Tagged 
landmarks include the His bundle and right coronary artery (RCA) ostium.  The successful ablation site (magenta 
dot) is approximately 8 mm inferior to the RCA ostium.                                                                     
Figure 6: Right atrial activation map of atypical (macroreentrant) atrial flutter, left to right, RAO, anteroposterior 
(AP), and LAO views. Once again, earliest activation has been defined to record areas of mid-diastolic electrical 
activity.   This corresponds to a narrow isthmus of atrial tissue (red isochrone) surrounded by large areas of 
myocardial scar (dense gray regions).   Two separate wavefronts are seen propagating through this isthmus in 
opposite directions, around two separate islands of scar, according to the color time scale.               
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Figure 7: Propagation map of the RA and LA during focal atrial tachycardia, LAO view.  Red coloration indicates 
atrial activation at different points in the cardiac cycle (proceeding from top to bottom) according to the time scale 
on the right of each panel.  Atrial activation is seen originating in the lateral LA (top most panel) and emanating in a 
centrifugal manner to activate the remainder of the LA and entire RA.  The SVC, tricuspid orifice, LSPV, LIPV, 
and RSPV (red segment visible just posterior to the SVC) have been marked. Cine Version available at website.
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Figure 8: Propagation map of the RA during macroreentrant RA tachycardia, LAO view. Activation is once again 
demarcated by red coloration, proceeding from left to right. Earliest activation (site of mid-diastolic activity) is seen 
in the superior RA, adjacent to an area of scar (gray), followed by activation along the medial, inferior, and 
posterolateral RA, in a circular manner, and according to the time scale.  The SVC, tricuspid orifice, His bundle 
(light   orange   points)   and   CS   have   been   marked.  Cine   Version   available   at   website.                    
Anatomic   mapping   with   CARTO                                                            
            In addition to facilitating activation mapping, the CARTO system provides location 
mapping features capable of recording sites of anatomic relevance, areas of low endocardial 
voltage representing scar, and areas of ablation. Structures such as the bundle of His can be 
tagged to prevent inadvertent energy delivery resulting in conduction impairment when ablating 
tachycardias originating in this region. Vessels such as the CS and PVs may also be marked to 
provide spatial orientation to assist mapping efforts (Figure 3 and 9). Scar mapping can also be 
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achieved by tracing the endocardial surface and recording the amplitude of local potentials. As 
with endocardial activation, a voltage scale may be arbitrarily chosen to display only the areas of 
lowest voltage amplitude, to distinguish between areas of scar, dense scar, and relatively normal 
tissue (Figures 9 and 10). Ablation can be performed to electrically isolate such areas, 
particularly when only non-sustained or hemodynamically unstable rhythms are induced. The 
"Remap" feature allows existing chamber geometry to be applied to separate activation maps, 
when differing arrhythmia morphologies originating from the same chamber are encountered.  In 
this situation, new activation timing points may be acquired by tracing a previously constructed 
shell of chamber anatomy. CARTO Merge is another feature that allows for superimposing a 
previously constructed computed tomography or magnetic resonance imaging and real-time 
acquired anatomic information through catheter mapping (Figure 11).
Figure 9: Voltage maps of the LA during sinus rhythm, posteroanterior (PA) view, before (left panel) and after 
(right panel) wide encircling ablation of the pulmonary veins for atrial fibrillation.  All four PVs have been marked. 
Local bipolar electrogram voltage of ≤ 0.5 mV has been arbitrarily selected as the threshold for low voltage, as 
depicted on the voltage scale on the right. The left panel demonstrates relatively normal bipolar electrogram voltage 
throughout the LA prior to ablation.  The right panel shows large areas of low electrogram voltage (red areas) 
following ablation, due to conduction block created  by encircling  ablation lesions (circular  red points). 
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Figure 10:  Voltage map of the left ventricle (LV), RAO and LAO view, in an individual with large, healed 
inferolateral myocardial infarction.  Local bipolar electrogram voltage of ≤ 0.5mV has been arbitrarily selected as 
the threshold for delineating low electrogram amplitude, as per the voltage scale on the right. The circumscribed 
area of red coloration represents sites of lowest electrogram amplitude, with the area of next lowest voltage 
demarcated by yellow, followed by green etc. The area colored in magenta indicates normal electrogram voltage. 
Figure 11:  Left panel, reconstructed computed tomography (CT) image of the LA and PVs, PA view.  
Right panel, PA view of the LA created by acquiring anatomic points through contact mapping (aqua coloration).  
These points are applied (and therefore "merged") to the previously obtained CT image, creating a "shell" of the LA 
to guide mapping and ablation.   Circumferential ablation surrounding the PVs is also shown (red points).
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            Several other EAM systems are presently available for clinical use, each employing 
differing technology to accomplish  the aforementioned tasks.   These systems are briefly 
reviewed here.
EnSite NavX® mapping system
            The EnSite NavX® system (Endocardial Solutions, St. Jude Medical, Inc., St. Paul, MN, 
USA) is capable of displaying 3D positions of multiple catheters.  This is achieved by applying a 
low-level 5.6 kHz current through orthogonally-located skin patches.  The recorded voltage and 
impedance at each catheter's electrodes generated from this current allows their distance from 
each skin patch, and ultimately, their location in space, to be triangulated with the help of a 
reference  electrode.   Three-dimensional  images   of  each   catheter  can   then  be  displayed.  
Respiratory motion artifact can also be eliminated to prevent confounding of actual catheter 
position.12 Chamber geometry can be determined thereafter by moving a mapping catheter along 
the endocardial surface.  (Figure 12)  Human studies have demonstrated feasibility and benefits 
when the EnSite NavX system is used in conjunction with conventional mapping strategies.19  In 
one study, significant reductions in fluoroscopy time, radiation dosage, and procedure time was 
observed with comparable success in achieving pulmonary isolation when the NavX system was 
used.12  Use of NavX was also associated with significantly reduced fluoroscopy time in the 
treatment of AV node reentry and typical atrial flutter, when compared to standard mapping 
techniques, without difference in procedure time. Overall, significantly less radiation dose was 
also seen with NavX.4   Strengths of the NavX system include the ability to simultaneously 
display multiple catheter positions in real-time, accurate representation of cardiac anatomy, and 
its compatibility with any EP catheter. Respiratory artifact is also minimized with current 
systems.   Disadvantages   include   limited   utility   against   non-sustained   arrhythmias,   though 
noncontact mapping can assist in this regard. Inaccurate rendition of complex anatomic 
structures can also occur unless meticulous contact mapping is performed in such areas.20  
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Figure 12: Electroanatomical maps acquired by the Ensite NavX system.  A.  Top.  Activation map of the LA 
during sinus rhythm, AP and PA views.  Bottom.  Simultaneously-acquired voltage map of the LA, demonstrating 
low-amplitude EGMs in the PV ostia.  B. Posteroanterior view of the LA and PVs.  Left. A decapolar encircling 
catheter and mapping/ablation catheter have engaged the LSPV ostium.  A decapolar catheter, located within the 
CS, is also displayed.  Right.  Magnified view of encircling and mapping catheters.                                   
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Noncontact   mapping                                                                                      
            The noncontact mapping system utilizes a multi-electrode array (MEA) catheter (Ensite, 
Endocardial Solutions Inc., St. Paul, MN, USA) to simultaneously record multiple areas of 
endocardial activation.21 The MEA is an inflatable balloon with 64 electrodes on its surface.  
(Figure 13)  Hence, relatively high-density mapping can be performed from even a single beat 
of tachycardia. Three-dimensional (3D) localization of the MEA surface electrodes is achieved 
by applying a low-level 5.6 kHz current between an electrode on the distal end of the MEA 
catheter and two ring electrodes along its shaft, proximal and distal to the MEA itself.  Similarly, 
a separate mapping catheter's position can be determined by delivering current between its 
electrode   and   these   two   ring   electrodes.   Chamber   geometry   can   be   reconstructed   by 
manipulating this mapping catheter within the chamber of interest and the corresponding 
electrical isopotentials can be "plotted" on this geometric representation of the endocardial 
surface.21,22  (Figure 14) In one animal study, the EnSite mapping system demonstrated accurate 
representation of local electrograms obtained from the MEA (both timing and waveform 
correlation) when compared to recordings taken from a standard mapping catheter. Accuracy of 
activation mapping was also assessed in this study by measuring the mean distance between the 
center and edge of ablation lesions from mapping of a target LV pacing site (4.0 ± 3.2 mm and 
1.2 ± 3.2 mm, respectively). In vitro testing showed the EnSite system to have excellent locator 
precision and accuracy at distances <50 mm from the MEA, though these parameters were less 
impressive at distances >50 mm.(21)  In one human LV mapping study, points were separated 
according to their location on or away from the MEA equatorial plane.  Electrogram timing and 
morphology from equatorial points obtained from the noncontact MEA correlated well with 
contact electrograms, though worsened with greater distance from the MEA: timing correlation 
significantly worsened at a threshold distance of >34 mm from the MEA center; a threshold 
distance for worsening electrogram morphology was not as clear.  For non-equatorial points, 
correlation of electrogram timing and morphology was comparable to that observed with 
equatorial points; a threshold distance where significant worsening of these parameters occurred 
was not observed.22 Advantages of the EnSite mapping system include acquisition of multiple 
endocardial electrograms from a single beat, rendering it quite useful in mapping atrial and 
ventricular ectopic beats, non-sustained arrhythmias, and rhythm disturbances that are poorly 
tolerated hemodynamically. Any mapping/ablation catheter is also compatible with this system. 
Disadvantages include inaccuracy of electrogram timing and morphology at greater distances 
from the MEA, difficulty in positioning the MEA balloon, and inaccuracy in reconstructing 
certain features of chamber geometry.20                                    
Figure 13: Multielectrode array balloon catheter in its non-deployed (left) and deployed (right) state.
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Figure 14: Electroanatomic maps acquired by using a MEA.  Left.  Activation map of macro-reentrant LA flutter. 
The arrows depict wavefront propagation within the flutter circuit.  Right.  Anatomical reconstruction of the RA.
Real-Time Position Management System                                                                   
            The Real-Time Position Management (RPM) System (Cardiac Pathways, Sunnyvale, 
CA, USA) employs ultrasound ranging to localize reference and mapping/ablation catheter 
positions.23  Two reference catheters, one typically situated in the RA, CS, or RV, and the 
mapping/ablation catheter each contain an ultrasound transducer along their shaft. A separate 
ultrasound transmitting and receiving device emits continuous ultrasound energy at 558.5 kHz. 
This energy is received by the transducers housed within the reference and ablation catheters; the 
time required to receive this signal by each transducer is converted to a distance (by utilizing a 
constant velocity of sound waves in blood) and the position of each catheter is thereby 
determined. Accuracy of this system has been verified in basic validation studies.23   Its 
feasibility and reliability in mapping atrial flutter, ventricular tachycardia, and accessory 
pathway-mediated tachycardia in humans have also been established.23  Specific advantages of 
the RPM system include continuous real-time location of ablation and reference catheters, the 
ability to demonstrate the degree of catheter deflection, and the capability of repositioning 
reference catheters to their original location should they become dislodged, as these locations 
can be stored.  Disadvantages of this system include potential limitations in recording anatomic 
features between separate cardiac structures (such as the left atrium (LA) and pulmonary veins 
[PVs]) that may lead to distortion of cardiac geometry, and the need to use specific reference and 
ablation catheters equipped with ultrasound transducers.20,23
            Table 1 summarizes currently available EAM systems, and each system's strengths and 
weaknesses.
            While EAM systems may greatly facilitate mapping efforts, reduce procedure time and 
fluoroscopic exposure, they must never replace fundamental principles of arrhythmia diagnosis 
and sound decision making; at most, such systems must be used as an adjunctive tool when 
approaching a target arrhythmia.  Wholly relying on data from an incorrectly acquired map may 
lead   to   an   erroneously   diagnosed   arrhythmia   mechanism,   inaccurate   site   of   tachycardia 
origination, or creation of a confusing, unhelpful activation map. Such errors may counteract any 
possible benefit offered by EAM, and may ultimately prolong procedure time and increase 
fluoroscopic exposure. (Figures 15 and 16)   It must also be remembered that while EAM 
system use may seem ubiquitous nowadays, procedural success rates prior to their widespread 
application are comparable to what is presently observed.1-7
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Table 1
   
Figure 15: Left panel.  Right atrial activation map of right atrial flutter (LAO view) obtained from using erroneous 
tachycardia cycle length of 350 ms.  Several different areas of red isochrones (area) indicating early activation are 
seen, yielding a confusing activation map. Right panel. Once the proper tachycardia cycle length (250 ms) has been 
applied, typical, counterclockwise, cavo-tricuspid isthmus dependent flutter is evident.  "Earliest" activation has 
been defined to record areas of mid-diastolic electrical activity,  and is represented by the red isochrone, 
anatomically corresponding to the cavo-tricuspid isthmus.  Wavefront propagation in a counterclockwise direction 
around the tricuspid annulus is seen according to the color time scale.  
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Figure 16: Left panel, activation map of the RA and LA of what was ultimately diagnosed as left AT.  The area of 
earliest activation (red isochrone) is observed to be in the anterolateral RA, however.  Inspection of the activation 
window (inset) corresponding to this seemingly early-activated point shows it was incorrectly recorded, using the 
ventricular, rather than the atrial EGM (arrow). Note the confusing features of this map: a very circumscribed area 
of early activation bordered by a large area of late activation (dark blue isochrone), accompanied by an adjacent area 
of intermediate-early activation (green and aqua isochrones) in the RA, and nearly uniform intermediate-early 
activation throughout the LA. Right panel, the erroneous activation map is rectified by correctly using the atrial 
EGM (arrow, inset) at aforementioned point.  The resulting activation map correctly shows earliest activation in the 
LA with uniform spread throughout both atria.  Ablation in the area of the red isochrone successfully eliminated 
AT.
Conclusion
            In summary, several EAM systems are available to facilitate cardiac arrhythmia mapping 
and ablation efforts, each distinguished by differing technology, and each with its own merits 
and weaknesses.  The decision to use a particular system depends on the data hoped to be gained 
by EAM (activation mapping, substrate mapping, cardiac geometry), the anticipated arrhythmia 
to be targeted, the compatibility of the system with adjunctive tools (i.e. diagnostic and ablation 
catheters), and perhaps most importantly, the user's familiarity with the chosen EAM system.  
While these systems provide a wealth of data and can substantially facilitate mapping efforts, 
reduce procedure time and fluoroscopic exposure, they cannot replace careful interpretation of 
data and strict adherence to electrophysiologic principles. 
References
1.  Haissaguerre M, Gaita F, Marcus F, Clementy J. Radiofrequency catheter ablation of 
accessory pathways: a contemporary review. J Cardiovasc Electrophysiol. 1994;5:532-52.        
2.  Naccarelli   G,   Shih   H,   Jalal   S.   Catheter   ablation   for   the   treatment   of   paroxysmal 
supraventricular tachycardia. J Cardiovasc Electrophysiol. 1995;6:951-61.                                 
3. Saxon L, Kalman J, Olgin J, Scheinman M, Lee R, Lesh M. Results of radiofrequency catheter 
ablation for atrial flutter. Am J Cardiol. 1996;77:1014-6.                                               
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8(1): 32-50 (2008)Deepak Bhakta, John M Miller, “Principles of Electroanatomic Mapping”                           49
4. Earley M, Showkathali R, Alzetani M, Kistler P, Gupta D, Abrams D, et al. Radiofrequency 
ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized 
trial.   Eur   Heart   J.   2006;27:1223-9.                                                      
5.  Kirchhof P, Loh P, Eckardt L, Ribbing M, Rolf S, Eick O, Wittkampf F, Borggrefe M, 
Breithardt   G   G,   Haverkamp   W.   A   novel   nonfluoroscopic   catheter   visualization   system 
(LocaLisa)   to   reduce   radiation   exposure   during   catheter   ablation   of   supraventricular 
tachycardias.   Am   J   Cardiol.   2002;90:340-3.                                                
6. Kopelman H, Prater S, Tondato F, Chronos N, Peters N. Slow pathway catheter ablation of 
atrioventricular nodal re-entrant tachycardia guided by electroanatomical mapping: a randomized 
comparison to the conventional approach. Europace. 2003;5:171-4.                                             
7. Sporton S, Earley M, Nathan A, Schilling R. Electroanatomic versus fluoroscopic mapping for 
catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 
2004;15:310-5.
8. Kottkamp H, Hugl B, Krauss B, Wetzel U, Fleck A, Schuler G, et al. Electromagnetic versus 
fluoroscopic mapping of the inferior isthmus for ablation of typical atrial flutter. A prospective 
randomized study. Circulation. 2000;102:2082-6.                                                                   
9. Schenider M, Ndrepepa G, Dobran I, Schreieck J, Weber S, Plewan A, et al. LocaLisa catheter 
navigation reduces fluoroscopy time and dosage in ablation of atrial flutter: a prospective 
randomized study. J Cardiovasc Electrophysiol. 2003;14:587-90.                                   
10. Ventura R, Rostock T, Klemm H, Lutomsky B, Demir C, Weiss C, et al. Catheter ablation of 
common-type atrial flutter guided by three-dimensional right atrial geometry reconstruction and 
catheter tracking using cutaneous patches: a randomized prospective study. J Cardiovasc 
Electrophysiol.   2004   15:1157-61.                                                          
11. Willems S, Weiss C, Ventura R, Ruppel R, Risius T, Hoffman M, et al. Catheter ablation of 
atrial flutter guided by electroanatomic mapping (CARTO): a randomized comparison to the 
conventional approach. J Cardiovasc Electrophysiol. 2000;11:1223-30.                        
12. Estner H, Deisenhofer I, Luik A, Ndrepepa G, von Bary C, Zrenner B, et al. Electrical 
isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy 
exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX). 
Europace.   2006;8:583-7.                                                                
13. Macle L, Jais P, Scavee C, Weerasooriya R, Hocini M, Shah D, et al. Pulmonary vein 
disconnection using the LocaLisa three-dimensional nonfluoroscopic catheter imaging system. J 
Cardiovasc Electrophysiol.  2003;14:693-7.                                                                 
14.  Rotter M, Takahashi Y, Sanders P, Haissaguerre M, Jais P, Hsu L, et al. Reduction of 
fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel 
anatomical navigation system. Eur Heart J. 2005;26:1415-21.                                       
15. Gepstein L, Hayam G, Ben-Haim S. A novel method for nonfluoroscopic catheter-based 
electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation. 
1997;95:1611-22.
16.  Shpun S, Gepstein L, Hayam G, Ben-Haim S. Guidance of radiofrequency endocardial 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8(1): 32-50 (2008)Deepak Bhakta, John M Miller, “Principles of Electroanatomic Mapping”                           50
ablation   with   real-time   three-dimensional   magnetic   navigation   system.   Circulation. 
1997;96:2016-21.
17. Hayam G, Gepstein L, Ben-Haim S. Accuracy of the in vivo determination of location using 
a new nonfluoroscopic electroanatomical mapping system. PACE. [Abstract]. 1996;19:712.  
18.  Smeets J, Ben-Haim S, Rodriguez L, Timmermans C, Wellens H. New method for 
nonfluoroscopic endocardial mapping in humans. Accuracy assessment and first clinical results. 
Circulation.   1998;97:2426-32.                                                                  
19.  Krum D, Goel A, Hauck J, Schweitzer J, Hare J, Attari M, et al. Catheter location, tracking, 
cardiac chamber geometry creation, and ablation using cutaneous patches. J Interv Card 
Electrophysiol.   2005;12:17-22.                                                            
20.  Packer D. Three-dimensional mapping in interventional electrophysiology: techniques and 
technology. J Cardiovasc Electrophysiol. 2005;16:1110-6.                                   
21.   Gornick C, Adler S, Pederson B, Hauck J, Budd J, Schweitzer J. Validation of a new 
noncontact catheter  system for electroanatomic mapping of left ventricular  endocardium. 
Circulation.   1999;99:829-35.                                                      
22.  Schilling R, Peters N, Davies D. Simultaneous endocardial mapping in the human left 
ventricle using a noncontact catheter. Comparison of contact and reconstructed electrograms 
during sinus rhythm. Circulation. 1998;98:887-98.                                                           
23.  De Groot N, Bootsma M, Van der Velde E, Schalij M. Three-dimensional catheter 
positioning during radiofrequency ablation in patients: first application of a real-time position 
management system. J Cardiovasc Electrophysiol. 2000;11:1183-92.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8(1): 32-50 (2008)